Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 3 2Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 6Unknown 2Terminated 2Recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Pain, Postoperative 2Breast Neoplasms 2Chronic Pain 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 90Gemcitabine 81Paclitaxel 80Docetaxel 73Capecitabine 64Oxaliplatin 53Specimen Handling 52Fluorouracil 52Magnetic Resonance Spectroscopy 50Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 44Leucovorin 39Drug Therapy 39Irinotecan 37Doxorubicin 36Pemetrexed 35Injections 30Trastuzumab 28Vincristine 27Rituximab 27Radiosurgery 25Prednisone 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24Letrozole 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Lidocaine × Clear all
NCT05072314 2026-03-25

LOLIPOP

Monash University

Phase 3 Recruiting
4,300 enrolled
Breast

Breast Neoplasms, Pain, Postoperative

NCT04874038 2025-11-17

Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)

University Health Network, Toronto

Phase 3 Recruiting
1,602 enrolled
Breast

Breast Neoplasms, Pain, Postoperative, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡